Inventor

COLLER BARRY S

US22 patents

⚠️ This page may combine multiple inventors who share the name “COLLER BARRY S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

COLLER BARRY S

UNIV NEW YORK STATE RES FOUND

Method for preparing targeted carrier erythrocytes

Peptidase resistant thrombin receptor peptide ligand

Platelet function inhibiting monoclonal antibody fragment

Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi

Method of inhibiting thrombus formation by the 7E3 monoclonal antibody

Anti-aggregatory agents for platelets

COLLER BARRY S

Controlled platelet activation to monitor therapy of ADP antagonists

Controlled platelet activation to monitor therapy of ADP antagonists

Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines

CENTOCOR INC

Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or fragments thereof, including c7E3

DNAs encoding chimeric immunoglobulin light or heavy chains and fragments thereof having variable regions derived from monoclonal antibody 7E3, and vectors and host cells comprising same

UNIV ROCKEFELLER

7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

Tetrahydronaphthyridinepentanamide integrin antagonists

BLUE ROBERT

Alpha-IIb-beta-3 inhibitors and uses thereof

Alpha-IIB-beta-3 inhibitors and uses thereof

UNIV NEW YORK RES FOUND

Platelet-specific chimeric 7E3 immunoglobulin

SINAI SCHOOL MEDICINE

Platelet blockade assay

ACCUMETRICS INC

Controlled platelet activation to monitor therapy of ADP antagonists

RES FOUNDATION FOR THE STATE U

Fibrinogen blocking monoclonal antibody

GEN HOSPITAL CORP

Method of treatment for myocardial infarction

US HEALTH

Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines

FRENETTE PAUL S

Methods of treating sickle cell disease